There are three sale recommendations in this issue. This issue also includes all of the company news items that were reported in the Interim Update released earlier this month, as well as news that's been announced since that time.

The first company IAS recommends in the May issue is new to the Service, a biotechnology business with a strong line-up in anti-inflammatory treatments. Our second pick is a familiar name to IAS subscribers, a large IT services company that's growing organically and by acquisition. Finally, IAS takes a renewed look at a past pick, a midsized real estate company with a sound foundation.